Physician profile
Mohammad A Bhatti
NPI 1093788101
$4,853.84
in general payments reported to CMS, 2019-2025
33 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $627 · 2021: $834 · 2022: $522 · 2023: $1,052 · 2024: $493 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.00 |
| Education | $190.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,137.83 | 2019-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $529.16 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $420.68 | 2019-2025 | |
| Antares Pharma, INC. | $384.43 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $292.66 | 2019-2024 | Speedicath |
| Olympus America INC. | $208.92 | 2025 | Itind System |
| Janssen Biotech, INC. | $195.00 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $181.09 | 2023 | Jelmyto |
| Boston Scientific Corporation | $157.94 | 2021-2023 | Spaceoar Vue System - 10ml, Rezum Generator |
| Sumitomo Pharma America, INC. | $139.42 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $138.91 | 2024 | Aquabeam System |
| Teleflex LLC | $129.06 | 2021-2023 | Urolift |
| Axonics, INC. | $123.21 | 2022 | |
| Myovant Sciences INC. | $95.66 | 2021-2022 | |
| Endo USA, INC. | $73.90 | 2024-2025 | Xiaflex, Aveed |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $67.30 | 2025 | Trelstar |
| Blue Earth Diagnostics | $61.25 | 2019-2025 | Posluma |
| Neotract INC. | $56.08 | 2020 | |
| 180 Medical, INC. | $50.37 | 2019-2023 | |
| Acerus Pharmaceuticals Corporation | $50.33 | 2021-2022 | |
| Medtronic USA, INC. | $47.83 | 2019 | |
| Telix Pharmaceuticals | $46.50 | 2024-2025 | Illuccix |
| Ambu INC. | $45.72 | 2023 | |
| Laborie Medical Technologies Corp. | $36.78 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $33.95 | 2023 | |
| Ferring Pharmaceuticals INC. | $28.26 | 2019 | |
| Mimedx Group, INC. | $25.28 | 2025 | |
| Abbvie INC. | $24.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.39 | 2023 | |
| Novo Nordisk INC | $14.61 | 2024 | Rivfloza |
| Amgen INC. | $14.55 | 2019 | |
| Tolmar, INC. | $14.09 | 2023 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.